Final Diagnosis: Infective Endocarditis Due to Granulicatella adiacens and Streptococcus mitis.
Toni Campanella, PharmD*
Advertisement
Articles by Toni Campanella, PharmD*
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Advertisement
Latest Updated Articles
- Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again
Published: February 13th 2020 | Updated:
- COVID-19 Complicates an Already Difficult Presentation of Infective Endocarditis
Published: June 17th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of November 29 - December 5
2
Early 2025 Influenza Vaccination Trends Following Prior Season and H3N2 Start
3
Delaying the Birth Dose of Hepatitis B Vaccine Could Lead to More Infections, Greater Costs
4
Public Education Strategies Could Aid Antibiotic Stewardship
5
